Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 81
Number Thumbnail Title Author Date Votes Views
81
김** | 2026.10.26 | Votes 0 | Views 136
김** 2026.10.26 0 136
80 Prestige Biopharma to Present Phase 1 Clinical Data for Pancreatic Cancer Drug Candidate PBP1510 at ESMO 2026
김** | 2026.10.23 | Votes 0 | Views 337
김** 2026.10.23 0 337
79 Prestige Biopharma Participates in CPHI Milan 2026 to Expand Global Partnerships
김** | 2026.10.07 | Votes 0 | Views 843
김** 2026.10.07 0 843
78 Prestige Biopharma IDC's Taeheung Kang, Director of Drug Development Division: 'Additional Pipelines Ready… Accelerating Resear
김** | 2026.10.01 | Votes 0 | Views 879
김** 2026.10.01 0 879
77 Prestige Biopharma Appoints Neil O’Connor as Board Director, Strengthening Expertise in CMC and Quality Management
김** | 2026.09.30 | Votes 0 | Views 750
김** 2026.09.30 0 750
76 Prestige Biopharma Receives Brazilian Marketing Authorization for Herceptin Biosimilar Tuznue
김** | 2026.09.28 | Votes 0 | Views 1040
김** 2026.09.28 0 1040
75 Prestige Biopharma’s Tuznue Receives Marketing Authorization in Trinidad and Tobago
김** | 2026.09.18 | Votes 0 | Views 1164
김** 2026.09.18 0 1164
74 Prestige Biopharma IDC Obtains ISO 14001 and ISO 45001 Certifications
김** | 2026.09.17 | Votes 0 | Views 942
김** 2026.09.17 0 942
73 Prestige Biopharma Successfully Concludes ‘Prestige Symposium’ on Aging
김** | 2026.09.09 | Votes 0 | Views 1487
김** 2026.09.09 0 1487
72 Prestige Biopharma IDC CEO Ko Sang-seok Purchases Company Shares on the Open Market
김** | 2026.09.03 | Votes 0 | Views 1890
김** 2026.09.03 0 1890

Read Prestige news >>